Regular Article
Three Novel Integrin β3 Subunit Missense Mutations (H280P, C560F, and G579S) in Thrombasthenia, Including One (H280P) Prevalent in Japanese Patients

https://doi.org/10.1006/bbrc.1998.9526Get rights and content

Abstract

We analyzed three unrelated Japanese patients with type II Glanzmann thrombasthenia (GT) for associated mutations. Polymerase chain reaction and subsequent direct sequencing of platelet RNA and genomic DNA revealed three single nucleotide substitutions of the integrin β3 subunit gene (His (CAT)-280 to Pro (CCT), Cys (TGT)-560 to Phe (TTT), and Gly(GGC)-579 to Ser(AGC)). Interestingly, the three unrelated patients all had the H280P mutation; one was homozygous and the other two heterozygous for this mutation. Ectopic expression of wild type and mutant complexes in Chinese hamster ovary cells revealed decreased surface expression of the mutated αIIbβ3 complexes, thus demonstrating that these mutations may result in the mild GT phenotypes. The identification of three unrelated patients having the same mutation (H280P) suggests that this mutation might be prevalent in the Japanese thrombasthenic population.

References (25)

  • C.M. Grimaldi et al.

    Blood

    (1998)
  • M. Poncz et al.

    J. Biol. Chem.

    (1987)
  • A.B. Zimrin et al.

    J. Biol. Chem.

    (1990)
  • D.L. French et al.

    Blood Cells Molecules Dis.

    (1997)
  • P.A. Castaldi et al.

    Lancet

    (1966)
  • T. Kamata et al.

    J. Biol. Chem.

    (1996)
  • W.P. Deng et al.

    Anal. Biochem.

    (1992)
  • A.L. Frelinger et al.

    J. Biol. Chem.

    (1990)
  • V.L.J. Woods et al.

    Blood

    (1984)
  • J. Ylänne et al.

    Blood

    (1988)
  • D.A. Cheresh et al.

    J. Biol. Chem.

    (1987)
  • A.-M. Cieutat et al.

    Biochem. Biophys. Res. Commun.

    (1993)
  • Cited by (40)

    • Disulfide bond exchanges in integrins αiIbβ3 and αvβ3 are required for activation and post-ligation signaling during clot retraction

      2014, Thrombosis Research
      Citation Excerpt :

      Although the precise disulfide bonds involved in the disulfide bond exchange-mediated activation of αIIbβ3 and αvβ3 have not been identified, our previous work suggested that there is a regulatory role for the C560-C583 bond in αIIbβ3 and αvβ3 activation [20,21]. Moreover, the C560S substitution mimics two naturally occurring C560R and C560F mutations that caused the severe bleeding disorder Glanzmann thrombasthenia and resulted in constitutive activation of αIIbβ3 [20,30,31], suggesting that this bond has a physiologic role in αIIbβ3 activation. The C523-C544 bond has an allosteric configuration in the αvβ3 crystal structure, a configuration associated with a functional role of disulfide bonds [21,32].

    • Specific cysteines in β3 are involved in disulfide bond exchange-dependent and -independent activation of αIIbβ3

      2008, Journal of Biological Chemistry
      Citation Excerpt :

      All of these mutants were inactive and could not be activated by the activating antibodies, implying that the integrity of the Cys-567–Cys-581 bond is important for the activation of αIIbβ3. So far, activation of αIIbβ3 by disulfide bond disruptions was mainly described for bonds in the EGF domains (14–18) but also in other regions such as the βTD (32). The βTD is unique for β integrins and contains four disulfide bonds, Cys-608–Cys-655, Cys-614–Cys-635, Cys-617–Cys-631, and Cys-663–Cys-687 (7).

    • Disruption of the β<inf>3</inf> 663-687 disulfide bridge confers constitutive activity to β<inf>3</inf> integrins

      2003, Blood
      Citation Excerpt :

      Studies of binding of platelets to monoclonal antibodies also suggest specific agonist-induced conformational changes in αIIbβ3.36 Furthermore, point mutations in β3 leading to conformational changes are associated with changes in the state of activation of αIIbβ3.37-42 Thus, a variety of experimental approaches support the contention that integrin activation is accompanied by conformational changes; however, the mechanisms by which the putative conformational changes increase the ligand binding affinity remain unclear.35

    View all citing articles on Scopus
    1

    H.A. and T.K. contributed equally to this study and should be regarded as cofirst authors.

    2

    To whom correspondence should be addressed. Makoto Handa, M.D., Blood Center, School of Medicine, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan. Fax: 81-3-3353-9706. E-mail:[email protected].

    View full text